Skip to search boxSkip to navigationSkip to main content

Immunogenic peptides from Pap31 and SCS-α of Bartonella bacilliformis: One step closer to a rapid diagnostic tool for Carrion’s disease

*Corresponding author for this work
  • Hospital Clínic – Universitat de Barcelona
    ,
  • ,
  • Universidad Peruana de Ciencias Aplicadas
    ,
  • Universidad Científica del Sur
    ,
  • Instituto de Investigación Nutricional
    ,
  • National Institute of Infectious Diseases
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

917

Journal (Volume, Issue Number)

Pathogens (Volume 10, Issue 8)

Publication milestones

  • Published - 08/2021

Publication status

Published - 08/2021

Publication IDs

  • Scopus: 85111660194

Abstract

Bartonella bacilliformis is the causal agent of Carrion’s disease, an overlooked illness endemic in the Andean Mountains with Peru being the most affected country. The diagnostic of this illness is a challenge due to the limited resources and the common symptomatology with other infectious diseases. The goal of this study was to identify immunogenic peptides from Pap31 and succinyl-CoA synthetase α (SCS-α) of B. bacilliformis that might be suitable for developing a serologic tool. The immunodominant character of Pap31 and SCS-α was determined byWestern blotting and in-silico analysis. Subsequently, 35 peptides were selected for epitope mapping and their immunoreactivity was tested by enzyme-linked immunosorbent assay (ELISA). A total of 30 sera were tested including pre-exposed people with high IgM levels for Pap31/SCS-α (23 sera), patients (2 sera) as well as 5 sera with no reactivity to Pap31/SCS-α. The results indicate that Pap31-8 (187QAIGSAILKGTKDTGT202) and SCS-α-12 (59IFASVAEGKEKTGANA74) are the most immunogenic peptides, with Pap31-8 showing potential to discriminate between B. bacilliformis and the remaining Bartonella spp., and SCS-α-12 differentiating Bartonella spp. from other microorganisms.

Funding Details

Funding: The study was supported by the Programa Nacional de Innovación para la Competitividad y Productividad (Innóvate Perú), under the contract 117-PNICP-PIAP-2015. J.R. had a fellowship from the program I3, of the ISCIII [grant number: CES11/012]. C.G. had a PhD fellowship of the ISCIII [FI12/00561] and was recipient of a Canon Foundation Fellowship and a Small Grant from the Royal Society for Tropical Medicine and Hygiene [grant reference 000584]. MJP had a postdoctoral fellowship from CONCYTEC/FONDECYT [grant number: CG05-2013-FONDECYT].
FundersFunding numbers
Programa Nacional de Innovación para la Competitividad y Productividad
117-PNICP-PIAP-2015
RSTMH
000584
ISCIII
CES11/012, FI12/00561
CONCYTEC
CG05-2013-FONDECYT

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Captures
14
Citations
4

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well